Stacy Ross - Angel Investor and Pharmaceutical Consultant

Professional Overview

Stacy Ross is an experienced angel investor, pharmaceutical consultant, and real estate investor, with a diverse background in the life sciences and consumer goods industries. As an angel investor, she leverages her deep technical expertise and broad commercial experience to identify and support promising startups. Concurrently, she provides strategic advisory services to pharmaceutical companies, specializing in chemistry, manufacturing, and controls (CMC) as well as financial independence and real estate investment.

Experience Summary

Current Roles

Angel Investor at VANE (2025-01-01 to Present)

Evaluates investment opportunities and provides strategic guidance to early-stage startups in the life sciences and consumer goods sectors

Leverages extensive industry knowledge and technical expertise to identify high-potential ventures and support their growth and development

Owner - Drug Product CMC Advisor at Ross Consulting LLC (2024-10-01 to Present)

Provides expert consulting services to pharmaceutical companies, specializing in CMC strategy, process development, and regulatory affairs

Collaborates with cross-functional teams to optimize drug product manufacturing and ensure compliance with industry standards and regulations

Financial Independence Consultant at Self-employed (2024-10-01 to Present)

Advises clients on achieving financial independence through strategic investment, budgeting, and wealth management

Draws on personal experience and expertise to develop customized plans for long-term financial stability and growth

Real Estate Investor at Self-employed (2019-01-01 to Present)

Manages a diversified real estate portfolio, including residential and commercial properties

Identifies and evaluates investment opportunities, oversees property management, and implements value-adding strategies

Previous Roles

Vice President CMC at Cellular Longevity, Inc., dba Loyal (2022-06-01 to 2024-10-01)

Led the CMC strategy and execution for a novel cellular therapy platform, ensuring seamless technology transfer and regulatory compliance

Collaborated with cross-functional teams to accelerate product development and secure funding for clinical trials

Director, CMC Project Lead at Sage Therapeutics (2022-01-01 to 2022-06-01)

Oversaw the CMC strategy and implementation for a pipeline of small-molecule drug candidates, guiding the team through key development milestones

Drove continuous process improvements and manufacturing optimization to enhance product quality and cost-effectiveness

Academic Background

Stacy holds a Ph.D. in Pharmaceuticals from The University of Iowa, where she specialized in formulation development and drug delivery systems.

Areas of Expertise

Chemistry, Manufacturing, and Controls (CMC) strategy and execution

Pharmaceutical product development and process optimization

Real estate investment and portfolio management

Financial planning and wealth management

Angel investing in the life sciences and consumer goods sectors

Professional Impact

Played a pivotal role in advancing the CMC strategy and manufacturing capabilities at Cellular Longevity, Inc., dba Loyal, enabling the successful progression of their novel cellular therapy platform

Leveraged her extensive CMC expertise to optimize the development and production of small-molecule drug candidates at Sage Therapeutics, contributing to the advancement of their pipeline

As an angel investor, has provided strategic guidance and financial support to several promising startups, helping to accelerate their growth and innovation

Conclusion

Stacy Ross is a versatile professional with a proven track record of success in the pharmaceutical industry, real estate investing, and angel investing. Her deep technical expertise, coupled with her entrepreneurial mindset and financial acumen, make her a valuable asset to the organizations and startups she supports. Stacy remains committed to driving innovation, optimizing operational performance, and empowering individuals and businesses to achieve their financial goals.